Saint Andrew's Society

Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024

Retrieved on: 
Jeudi, mai 30, 2024

“In addition to physician and caregiver presentations in pediatric GHD, we look forward to our first in-person opportunity to share data from foresiGHt, our pivotal trial of TransCon hGH in adults with GHD,” said Aimee Shu, M.D., Ascendis Pharma’s Senior Vice President of Clinical Development, Endocrine Medical Sciences.

Key Points: 
  • “In addition to physician and caregiver presentations in pediatric GHD, we look forward to our first in-person opportunity to share data from foresiGHt, our pivotal trial of TransCon hGH in adults with GHD,” said Aimee Shu, M.D., Ascendis Pharma’s Senior Vice President of Clinical Development, Endocrine Medical Sciences.
  • “And with World Hypoparathyroidism Day coinciding with the first day of ENDO, we are pleased to host an informational booth focused on deepening physician awareness of the significant health and quality-of-life impacts of hypoparathyroidism.”
    Ascendis presentations during ENDO 2024 include:
    June 3, 2:45 – 3:00 p.m ET.
  • Baseline Demographics and Design of the SkybriGHt Registry Study.
  • A US Multi-Center, Prospective, Non-Interventional, Long-Term Effectiveness and Safety Study of Children and Adolescents with Growth Hormone Deficiency Treated with Lonapegsomatropin

Sparrow Pharmaceuticals’ David Katz, PhD, to Receive Outstanding Innovation Award at the 2024 Annual Endocrine Society Conference

Retrieved on: 
Jeudi, mai 30, 2024

Sparrow Pharmaceuticals, announced today that it will be attending the Endocrine Society (ENDO) 2024 Annual Conference .

Key Points: 
  • Sparrow Pharmaceuticals, announced today that it will be attending the Endocrine Society (ENDO) 2024 Annual Conference .
  • Notably, Sparrow’s Founder and Chief Scientific Officer, Dr. David A. Katz will be the 2024 Laureate Recipient of the Outstanding Innovation Award.
  • This award is bestowed upon an individual who has demonstrated innovation to further endocrine research or practice in the field of endocrinology.
  • “I thank the Endocrine Society for recognition of the Sparrow team and our research partners as we develop SPI-62 for patients who suffer the adverse effects of glucocorticoid excess,” said David A. Katz, PhD., Chief Scientific Officer, Sparrow Pharmaceuticals.

Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)

Retrieved on: 
Mardi, mai 28, 2024

On April 22, Corcept announced that patients in GRACE’s initial, open-label phase exhibited clinically meaningful and statistically significant improvements in hypertension, hyperglycemia and other symptoms experienced by patients with Cushing’s syndrome.

Key Points: 
  • On April 22, Corcept announced that patients in GRACE’s initial, open-label phase exhibited clinically meaningful and statistically significant improvements in hypertension, hyperglycemia and other symptoms experienced by patients with Cushing’s syndrome.
  • GRACE met its primary endpoint of loss of blood pressure control in the randomized withdrawal phase among patients receiving relacorilant as compared to placebo (odds ratio: 0.17; p-value: 0.02).
  • Consistent with its known safety profile, relacorilant was well-tolerated in both phases of GRACE, with no differences in the randomized withdrawal phase between the relacorilant and placebo groups.
  • “The data from GRACE make a compelling case for the use of relacorilant in patients with endogenous hypercortisolism.

Breakthroughs in AI Chips and Image Recognition Propel Market Growth and Business Enhancements

Retrieved on: 
Lundi, mai 13, 2024

VANCOUVER, BC, May 13, 2024 /PRNewswire/ -- USA News Group – The race to improve artificial intelligence (AI) is accelerating at breakneck speed, with China recently unveiling a new photon-powered neural network microchip that can run on a thousandth as much energy as common electron-powered chips. According to analysts at DataHorizzon Research the AI Chip Market is set for explosive growth of over 40.6% CAGR through to 2032. As new chips improve, so too do the ways we use the chips to enhance businesses through AI-powered deep machine learning and neural networks. In one aspect that's consistently improving is AI-powered image recognition, which Research and Markets projects to grow at a CAGR of 16.1% towards US$98.6 billion by 2029. This portion of the AI revolution is being rapidly implemented and improved by developers including Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF), Ambarella, Inc. (NASDAQ: AMBA), Ceva, Inc. (NASDAQ: CEVA), Himax Technologies, Inc. (NASDAQ: HIMX), and Autodesk, Inc. (NASDAQ: ADSK).

Key Points: 
  • According to analysts at DataHorizzon Research the AI Chip Market is set for explosive growth of over 40.6% CAGR through to 2032.
  • As new chips improve, so too do the ways we use the chips to enhance businesses through AI-powered deep machine learning and neural networks.
  • As the capabilities of deep machine learning expand across various industries, Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) has rebranded and broadened its market reach.
  • By integrating object visual recognition, Scope AI is enhancing the ability of companies to personalize ad content, create immersive gaming experiences, and utilize neural networks for diverse applications.

Breakthroughs in AI Chips and Image Recognition Propel Market Growth and Business Enhancements

Retrieved on: 
Lundi, mai 13, 2024

VANCOUVER, BC, May 13, 2024 /PRNewswire/ -- USA News Group – The race to improve artificial intelligence (AI) is accelerating at breakneck speed, with China recently unveiling a new photon-powered neural network microchip that can run on a thousandth as much energy as common electron-powered chips. According to analysts at DataHorizzon Research the AI Chip Market is set for explosive growth of over 40.6% CAGR through to 2032. As new chips improve, so too do the ways we use the chips to enhance businesses through AI-powered deep machine learning and neural networks. In one aspect that's consistently improving is AI-powered image recognition, which Research and Markets projects to grow at a CAGR of 16.1% towards US$98.6 billion by 2029. This portion of the AI revolution is being rapidly implemented and improved by developers including Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF), Ambarella, Inc. (NASDAQ: AMBA), Ceva, Inc. (NASDAQ: CEVA), Himax Technologies, Inc. (NASDAQ: HIMX), and Autodesk, Inc. (NASDAQ: ADSK).

Key Points: 
  • According to analysts at DataHorizzon Research the AI Chip Market is set for explosive growth of over 40.6% CAGR through to 2032.
  • As new chips improve, so too do the ways we use the chips to enhance businesses through AI-powered deep machine learning and neural networks.
  • As the capabilities of deep machine learning expand across various industries, Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) has rebranded and broadened its market reach.
  • By integrating object visual recognition, Scope AI is enhancing the ability of companies to personalize ad content, create immersive gaming experiences, and utilize neural networks for diverse applications.

Ultimate Medical Academy Extends “Ripple Effect of Care” Through Community Partnership and Service

Retrieved on: 
Mercredi, mai 8, 2024

“At UMA, it starts with care for our team members who then extend care to our learners.

Key Points: 
  • “At UMA, it starts with care for our team members who then extend care to our learners.
  • As graduates, those learners pass care along to patients through their work with our healthcare employers nationwide.”
    The Ripple Effect of Care also extends into UMA’s communities through philanthropy, partnership and volunteerism, which is a cornerstone of UMA's community engagement.
  • For UMA, the ripple effect of care isn't just a philosophy—it's a lived reality, creating waves of positive change that resonate far and wide.
  • To learn more about Ultimate Medical Academy's community initiatives and view the full report, visit: Community Outreach | Giving Back | Ultimate Medical Academy

TUN TAVERN LEGACY FOUNDATION SECURES LAND TO REBUILD HISTORIC SITE IN PHILADELPHIA

Retrieved on: 
Mardi, avril 30, 2024

PHILADELPHIA, April 30, 2024 /PRNewswire/ -- The Tun Tavern Legacy Foundation, Inc. (Foundation), a 501(c)(3) nonprofit organization, today announced it acquired land to rebuild and reestablish an authentic reproduction of the original Tun Tavern building in Philadelphia. The Tun, constructed in 1693, is the birthplace of Freemasonry in Pennsylvania (1731) and the first documented lodge in North America, and the founding place of the St. Andrew's Society (1747), and the United States Marine Corps (1775). It is also the early first meeting place of the Friendly Sons & Daughters of St. Patrick (established 1771), the Society of St. George (founded in 1772, with earlier meetings at Tun Tavern), and is purportedly the place where John Adams and the Naval Committee met and drafted documents that outline the structure for what became the United States Navy (1775). A groundbreaking ceremony is planned for November 2024 in advance of the Navy and Marine Corps' 250th Homecoming Celebration in 2025.

Key Points: 
  • The Tun™ will be located at 19 S. 2nd Street in Philadelphia's Old City neighborhood, known as "America's most historic square mile."
  • The location is within 250 yards of the original Tun Tavern site at Water Street and Tun Alley on Philadelphia's waterfront, where the Tun stood until 1781.
  • With the land acquisition, we have a strong base to move forward with the fundraising necessary to rebuild the historic Tun Tavern," said Rob Brink, Foundation Board Chair and Deputy Grand Master of the Grand Lodge of Pennsylvania Free and Accepted Masons.
  • "The Foundation will operate The Tun™ as a functioning mariner's tavern and restaurant reminiscent of colonial Philadelphia.

DEEPX Expands First-Generation AI Chips into Intelligent Security and Video Analytics Markets

Retrieved on: 
Vendredi, avril 19, 2024

LAS VEGAS and SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- DEEPX, an on-device AI semiconductor company, is announcing plans to expand its first-generation AI chip lineup to focus on the intelligent video analytics and security system market — an expansion driven by key business alliances with global physical security companies, physical security device OEM/ODMs, and IDH companies. To this end, the company recently had an exclusive booth at ISC West (The International Security Conference and Exposition), the world's largest security exhibition held from April 9th to 12th in Las Vegas, USA, where it met with more than 400 companies and more than 600 business representatives from leading global security companies.

Key Points: 
  • LAS VEGAS and SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- DEEPX , an on-device AI semiconductor company, is announcing plans to expand its first-generation AI chip lineup to focus on the intelligent video analytics and security system market — an expansion driven by key business alliances with global physical security companies, physical security device OEM/ODMs, and IDH companies.
  • The global AI video analytics market is expected to grow at a CAGR of 33% from $18.11 billion in 2023 to $75.35 billion by 2028.
  • Faced with communication delays, privacy issues, and network costs in systems that previously ran AI on the cloud or central servers, these markets require the realization of intelligent video analysis functions in real time using on-device AI semiconductors.
  • In addition, a reorganization of the physical security industry's global supply chains is creating an opportunity for DEEPX to accelerate the expansion of its on-device AI solutions.

UK loses 150 million working days due to lack of workplace support for women's health, reveals Benenden Health

Retrieved on: 
Mardi, février 20, 2024

Perhaps unsurprisingly, this has left many women reluctant to discuss their health issues with managers, with almost half (42%) feeling uncomfortable doing so.

Key Points: 
  • Perhaps unsurprisingly, this has left many women reluctant to discuss their health issues with managers, with almost half (42%) feeling uncomfortable doing so.
  • However, the percentage of women comfortable discussing health issues increases significantly – up to 96% - when the manager is also female.
  • Benenden Health is private healthcare done different, believing that no matter who you are and what your medical history is, you deserve access to great healthcare.
  • For more information on Benenden Health's latest campaign and how to better support your female workforce visit: https://www.benenden.co.uk/gender-health-gap-2024/

Introducing APPLE & BEARS Leisure Trade Platform: Catering for the Hoteliers, Gym Owners, Spa, and Affiliates

Retrieved on: 
Jeudi, février 15, 2024

LONDON, Feb. 15, 2024 /PRNewswire/ -- APPLE & BEARS, a distinguished name in luxury natural skincare, proudly unveils the APPLE & BEARS Leisure Trade Platform, specially designed to cater to the discerning needs of hoteliers, gym owners, spas, and affiliates.

Key Points: 
  • LONDON, Feb. 15, 2024 /PRNewswire/ -- APPLE & BEARS, a distinguished name in luxury natural skincare, proudly unveils the APPLE & BEARS Leisure Trade Platform, specially designed to cater to the discerning needs of hoteliers, gym owners, spas, and affiliates.
  • Vegetarian Society Vegan-Approved: Committed to providing ethical choices, APPLE & BEARS products are Vegan-approved by the Vegetarian Society.
  • Environmental Commitment for a Sustainable Future:
    At the heart of APPLE & BEARS ethos lies a steadfast commitment to environmental responsibility.
  • Join the APPLE & BEARS Leisure Trade Community:
    Become a trade member to unlock exclusive benefits, including preferential pricing, tailored promotional materials, and first-hand information on the latest releases.